Day Trading Reports
  • Business
  • World News
  • Politics
  • Investing
  • Business
  • World News
  • Politics
  • Investing

Day Trading Reports

Investing

First patient dosed in Phase IIb imaging for Brain Mets

by admin April 28, 2025
April 28, 2025
First patient dosed in Phase IIb imaging for Brain Mets

Radiopharm Theranostics (RAD:AU) has announced First patient dosed in Phase IIb imaging for Brain Mets

Download the PDF here.

This post appeared first on investingnews.com

previous post
Binding Commitments Received for A$1.0 Million under Convertible Note Placement
next post
RHI: Acqn of royalty over Sandstone Gold Project tenements

Related Posts

Trading Halt

December 4, 2025

MXR: Extension of Takeover Offer Period

March 7, 2025

Presenting on Emerging Growth Conference 81 Day 1...

April 16, 2025

Flow Metals Announces Closing of Shares for Debt

January 31, 2026

Two Water Wells Completed & Staking Finalised at...

January 30, 2025

Appoints global biopharma leader Paul Carter as Non-Executive...

October 28, 2025

Westport Announces the Resignation of Chief Financial Officer...

August 27, 2025

Crypto Market Recap: Bybit Suffers US$1.5 Billion Hack,...

February 25, 2025

Tech Weekly: Chip Stocks Soar on Taiwan Semiconductor...

January 17, 2026

Tech Weekly: Cloud Providers, Tech Stocks Outperform as...

October 25, 2025

    Become a VIP member by signing up for our newsletter. Enjoy exclusive content, early access to sales, and special offers just for you! As a VIP, you'll receive personalized updates, loyalty rewards, and invitations to private events. Elevate your experience and join our exclusive community today!


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Editors’ Picks

    • 1

      Mega M&A: Rio Tinto-Glencore Merger Sparks Chatter

      January 28, 2025
    • 2

      Forum Energy Metals and Global Uranium Announce Exploration Update on Drill Targeting, Northwest Athabasca Project, Saskatchewan

      January 31, 2025
    • 3

      Excellent 90% recoveries at Cork Tree Well & Board Update

      February 17, 2025
    • 4

      Environmental Approval for Boland Infield Studies & Update on Scaled Column ISR Test

      September 19, 2025
    • 5

      Rare Earths Stocks: 9 Biggest Companies in 2025

      April 8, 2025
    • 6

      Financial Agreement signed releasing $2M grant

      January 23, 2025
    • 7

      Netflix shares soar as company reports surging revenue, tops 300 million subscribers

      January 23, 2025
    • Terms and conditions
    • Privacy Policy

    Disclaimer: daytradingreports.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.


    Copyright © 2026 daytradingreports.com | All Rights Reserved